BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 3037727)

  • 21. 24,25(OH)2D3 enhances the calcemic effect of 1,25(OH)2D3 in PTX rats.
    Wald H; Traves J; Popovtzer MM
    Proc Soc Exp Biol Med; 1987 Jan; 184(1):47-9. PubMed ID: 3491995
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 25-Hydroxycholecalciferol and 1,25-dihydroxycholecalciferol enhances phosphaturia in rats with reduced renal mass: evidence for a PTH-dependent mechanism.
    Rubinger D; Wald H; Popovtzer MM
    Miner Electrolyte Metab; 1990; 16(6):348-54. PubMed ID: 1965220
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative effects of some hydroxylated vitamin D metabolites on parathyrin secretion by dispersed rat parathyroid cells in vitro.
    Gruson M; Demignon J; Del Pino Montes J; Miravet L
    Steroids; 1982 Sep; 40(3):275-85. PubMed ID: 6985176
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term administration of vitamin D3 metabolites alters PTH-responsive osteoblastic adenylate cyclase in rats.
    Mortensen B; Gordeladze JO; Aksnes L; Gautvik KM
    Calcif Tissue Int; 1990 May; 46(5):339-45. PubMed ID: 2159835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of 1,25- and 24,25-dihydroxycholecalciferol on parathyroid hormone release from human parathyroid cells in vitro.
    Rudberg C; Akerström G; Johansson H; Ljunghall S; Malmaeus J; Wide L
    Acta Endocrinol (Copenh); 1984 Mar; 105(3):354-9. PubMed ID: 6608201
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction of the parathyroid and 1,25-dihydroxyvitamin D3 in the control of renal 25-hydroxyvitamin D3 metabolism.
    Omdahl JL
    J Biol Chem; 1978 Dec; 253(23):8474-8. PubMed ID: 711762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blockade of the renal tubular effects of vitamin D by cycloheximide in the rat.
    Brezis M; Wald H; Shilo R; Popovtzer MM
    Pflugers Arch; 1983 Aug; 398(3):247-52. PubMed ID: 6688870
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Calcium receptor messenger ribonucleic acid levels in the parathyroid glands and kidney of vitamin D-deficient rats are not regulated by plasma calcium or 1,25-dihydroxyvitamin D3.
    Rogers KV; Dunn CK; Conklin RL; Hadfield S; Petty BA; Brown EM; Hebert SC; Nemeth EF; Fox J
    Endocrinology; 1995 Feb; 136(2):499-504. PubMed ID: 7835282
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stimulation of 24R,25-dihydroxyvitamin D3 synthesis by metabolites of vitamin D3.
    Reddy GS; Jones G; Kooh SW; Fraser D; DeLuca HF
    Am J Physiol; 1983 Oct; 245(4):E359-64. PubMed ID: 6312806
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bone turnover in rats treated with 1,25-dihydroxyvitamin D3, 25-hydroxyvitamin D3 or 24,25-dihydroxyvitamin D3.
    Mortensen BM; Gautvik KM; Gordeladze JO
    Biosci Rep; 1993 Feb; 13(1):27-39. PubMed ID: 8392394
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 1,25-dihydroxyvitamin D-3 and 24,25-dihydroxyvitamin D-3 affect parathormone (PTH) -sensitive adenylate cyclase activity and alkaline phosphatase secretion of osteoblastic cells through different mechanisms of action.
    Klem KH; Jablonski G; Saether O; Jarosz G; Gautvik KM; Gordeladze JO
    Biochim Biophys Acta; 1990 Sep; 1054(3):304-10. PubMed ID: 2169895
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent advances in our understanding of the vitamin D endocrine system.
    De Luca HF
    J Lab Clin Med; 1976 Jan; 87(1):7-26. PubMed ID: 173767
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of a direct effect of 1,25-dihydroxycholecalciferol on parathyroid hormone secretion by normal bovine parathyroid glands.
    Golden P; Greenwalt A; Martin K; Bellorin-Font E; Mazey R; Klahr S; Slatopolsky E
    Endocrinology; 1980 Aug; 107(2):602-7. PubMed ID: 6893023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of dietary calcium in the physiology of vitamin D toxicity: excess dietary vitamin D3 blunts parathyroid hormone induction of kidney 1-hydroxylase.
    Beckman MJ; Johnson JA; Goff JP; Reinhardt TA; Beitz DC; Horst RL
    Arch Biochem Biophys; 1995 Jun; 319(2):535-9. PubMed ID: 7786039
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The hypercalcemic Walker carcinosarcoma 256 of the rat causes an increase in serum 1,25-dihydroxyvitamin D3.
    Scharla SH; Minne HW; Oswald C; Lempert UG; Schmidt-Gayk H; Ziegler R
    Bone Miner; 1989 May; 6(2):155-64. PubMed ID: 2765706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolism of 1,25-dihydroxyvitamin D3.
    Kumar R
    Physiol Rev; 1984 Apr; 64(2):478-504. PubMed ID: 6324253
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vitamin D metabolism in hyperthyroidism.
    MacFarlane IA; Mawer EB; Berry J; Hann J
    Clin Endocrinol (Oxf); 1982 Jul; 17(1):51-9. PubMed ID: 6981469
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects in vivo of vitamin D metabolites and 17 beta-estradiol on parathyroid hormone-dependent formation of adenosine 3',5'-monophosphate in rat bone.
    Marcus R; Orner FB; Brickman AS
    Endocrinology; 1980 Nov; 107(5):1593-9. PubMed ID: 6253269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The kidney as an endocrine organ involved in the function of vitamin D.
    DeLuca HF
    Am J Med; 1975 Jan; 58(1):39-47. PubMed ID: 163578
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Does 24,25 dihydroxycholecalciferol have a physiological and pathophysiological role?].
    Sebert JL; Fournier A; Lambrey G; Morinière P; Decourcelle PH; Makdassi R; De Frémont JF
    Nephrologie; 1982; 3(3):133-41. PubMed ID: 6292757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.